CL Workshop Group Ltd has announced a significant change in its financial oversight. On November 9, 2026, the company’s audit committee recommended, and the board approved, the appointment of Harmony CPA LLP as its new independent auditor. This decision comes as the company seeks to enhance its financial reporting and oversight.
The transition from WWC, P.C. to Harmony CPA is effective immediately. This change is noteworthy as it follows a report from WWC that raised concerns about the company’s ability to continue as a going concern, although their report did not contain any adverse opinions or disclaimers regarding the company’s financial statements.
Background
CL Workshop Group Ltd, which operates under the SIC code 2400, is classified within the lumber and wood products industry, specifically excluding furniture. The company is listed on the Nasdaq under the ticker NWGL and is categorized as an accelerated filer and emerging growth company. Its principal executive office is located in Macau S.A.R.
What the Filing Says
The filing states, "The Company has provided WWC with a copy of the above disclosure and requested that WWC furnish a letter addressed to the U.S. Securities and Exchange Commission stating whether or not it agrees with the above statements." This indicates a level of transparency as the company seeks to maintain open lines of communication with its previous auditor and regulatory bodies.
Impact
This change in auditors may affect various stakeholders, including investors, employees, and customers. Investors may be particularly interested in how this shift will influence the company's financial reporting and overall stability. Employees may also be impacted as the company adjusts its financial practices, potentially leading to changes in operational procedures.
What’s Next
The filing does not say what happens next.
Read Next
Alps Group Regains Compliance with Nasdaq Listing Standards
Ainos, Inc. Receives Nasdaq Delisting Notice Over Equity
Compass Therapeutics Receives Nasdaq Deficiency Notice
60 Degrees Pharmaceuticals Faces Nasdaq Delisting Risk
Biofrontera Inc. Faces Nasdaq Delisting Due to Low Stock Price
Senti Biosciences dismisses KPMG, appoints new auditor KNAV










